Skip to main content
. 2022 Nov 24;11(4):74. doi: 10.3390/antib11040074

Figure 2.

Figure 2

Evaluation of EpMab-37-mG2a-f mediated ADCC and CDC activities in BT-474 and Capan-2 cells. (A,C) ADCC elicited by EpMab-37-mG2a-f or control mouse IgG2a against BT-474 (A) and Capan-2 (C) cells. (B,D) CDC elicited by EpMab-37-mG2a-f or control mouse IgG2a against BT-474 (B) and Capan-2 (D) cells. Values are shown as mean ± SEM. Asterisks indicate statistical significance (** p < 0.01, * p < 0.05; Welch’s t-test). ADCC, antibody-dependent cellular cytotoxicity; CDC, complement-dependent cytotoxicity.